Challenges and solutions in an expanding TAVI world

Sponsored by Medtronic

Anchorperson: M. Abdel-Wahab

Spokesperson: D. Blackman

Summary

This EuroPCR 2025 session addresses key challenges and emerging solutions in today’s rapidly evolving TAVI landscape. It presents the latest evidence on valve replacement in low-risk patients with aortic stenosis, alongside strategies for navigating the complexities of lifetime management in TAVI candidates. The programme features a detailed ViV TAVI case—from patient presentation and imaging to procedural planning—highlighting the nuances of revalving techniques. It also explores the importance of the initial valve choice and planning for redo TAVI, with a focus on evolving technologies and procedural innovations shaping the future of transcatheter aortic care.

Learning Objectives

To understand the most recent evidence in low-risk patients with aortic stenosis undergoing valve replacement
To learn how to overcome challenges in lifetime management in patients considered for TAVI
To appreciate innovations in technique and technology for revalving procedures